REFERENCES

• KannerAM.BalabanovA.Depression in epilepsy: How closely related are these two disorders?Neurology.200258 (suppl 5)S27S3911971130
   PubMed Web of Science ®Google Scholar
• Tellez-ZentenoJF.PattenSB.JetteN.WilliamsJ.WiebeS.Psychiatric comorbidity in epilepsy: a population-based analysis.Epilepsia.2007482336234417662062
   PubMed Web of Science ®Google Scholar
• MazaratiA.ShinD.AuvinS.CaplanR.SankarR.Kindling epileptogenesis in immature rats leads to persistent depressive behavior.Epilepsy Behav.20071037738317368107
   PubMed Web of Science ®Google Scholar
• SchildkrautJJ.The catecholamine hypothesis of effective disorders: a review of supporting evidence.Am J Psychiatry.19651225095225319766
   PubMed Web of Science ®Google Scholar
• JobePC.WeberRH.Affective disorder and epilepsy comorbidity in the genetically epilepsy prone-rat (GEPR). In: Gilliam FG, Kanner AM, Sheline Yl, eds.Depression and Brain Dysfunction.London, UK: Taylor & Francis2006121158
   Google Scholar
• CloughRW.PetersonBR.SteenbergenJL.et al.Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): An in vitro study on locus coeruleus.Epilepsy Res.1998291351469477146
   PubMed Web of Science ®Google Scholar
• RyuJR.JobePC.MilbrandtJC.et al.Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues.Exp Neurol.1999156849110192779
   PubMed Web of Science ®Google Scholar
• YanQS.JobePC.DaileyJW.Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat.Epilepsy Res.1993142292368504793
   PubMed Web of Science ®Google Scholar
• DaileyJW.MishraPK.KoKH.PennyJE.JobePC.Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsyprone rats.Life Sci.1992503193261732702
   PubMed Web of Science ®Google Scholar
• YanQS.JobePC.DaileyJW.Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy prone rats.Br J Pharmacol.1995115131413187582562
   PubMed Web of Science ®Google Scholar
• YanQS.JobePC.DaileyJW.Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsyprone rats.Eur J Pharmacol.19932521051128149989
   PubMed Web of Science ®Google Scholar
• LehmannA.Audiogenic seizures data in mice supporting new theories of biogenic amines mechanisms in the central nervous system.Life Sci.1967614236035770
   PubMedGoogle Scholar
• PoleP.SchneebergerJ.HaefelyWEffects of several centrally active drugs on the sleep wakefulness cycle of cats.Neuropharmacology.19791825935763
   PubMed Web of Science ®Google Scholar
• PietteY.DelaunoisAL.De ShaepdryverAF.HeymansC.Imipramine and electroshock threshold.Arch Int Pharmacodyn Ther.196314429314047156
   PubMedGoogle Scholar
• YanagitaT.WakasaY.KiyoharaH.Drug-dependance potential of viloxazine hydrochloride tested in rhesus monkeysPharmacol Biochern Behav.198012155
   PubMed Web of Science ®Google Scholar
• BeckSG.ChoiKC.5-Hydroxytryptamine hyperpolartizes CA3 hippocampal pyramidal cells through an increase in potassium conductanceNeurosci Lett.199113393961792002
   PubMed Web of Science ®Google Scholar
• YanQS.MishraPK.BurgerRL.BettendorfAF.JobePC.DaileyJW.Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.J Pharmacol Exp Ther.19922616526591374472
   PubMed Web of Science ®Google Scholar
• SouthamE.KirkbyD.HigginsGA.HaganRM.Lamotrigine inhibits monoamine uptake in vitro and modulates 5hydroxytryptamine uptake in rats.Eur J Pharmacol.199835819249809864
   PubMed Web of Science ®Google Scholar
• WhittonPS.FowlerLJ.The effect of valproic acid on 5-hydroxytryptamine and 5-hydroxyindoleacetic acid concentration in hippocampal dialysates in vivo.Eur J Pharmacol.19912001671691722752
   PubMed Web of Science ®Google Scholar
• Lopez-MerazML.Gonzalez-TrujanoME.Neri-BazanL.HongE.RochaLL.5-HT1 A receptor agonists modify seizures in three experimental models in rats.Neuropharmacology.20054936737515993434
   PubMed Web of Science ®Google Scholar
• ClinckersR.SmoldersI.MeursA.EbingerG.MichotteY.Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxicarbamazepine.Neurosci Lett.200516:390485316139430
   PubMed Web of Science ®Google Scholar
• ClinckersR.SmoldersI.MeursA.EbingerG.MichotteY.Quantitative in-vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity,J Pharmacol Exp Ther.200531472573115860570
   PubMed Web of Science ®Google Scholar
• NaritokkuDK.TerryWJ.aHelfertRH.Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve.Epilepsy Res.199522538565967
   PubMed Web of Science ®Google Scholar
• BrowningRaClarkKB.NaritokuDKSmithDC.JensenRA.Loss of anticonvulsant effect of vagus nerve stimulation in the pentylenetetrazol seizure model following treatment with 6-hydroxydopamine or 5,7-dihydroxy-tryptamine.Soc Neurosci.1997232424
   Google Scholar
• LangerSZ.GalzinAM.Studies on the serotonin transporter in platelets.Experientia.1988441271302964377
   PubMedGoogle Scholar
• NemeroffCB.KnightDL.KrishnanRR.et al.Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression.Arch Gen Psychiatry.1988459199232844132
   PubMed Web of Science ®Google Scholar
• MalisonRT.PriceLH.BermanR.et al.Reduced brain serotonin transporter availability in major depression as measured by[123l]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.Biol Psychiatry.199844109010989836013
   PubMed Web of Science ®Google Scholar
• OgilvieAD.HarmarAJ.Association between the serotonin transporter gene and affective disorder: the evidence so far.Mol Med.1997390939085252
   PubMed Web of Science ®Google Scholar
• SargentPA.KjaerKH.BenchCJ.RabinerEA.MessaC.MeyerJ.GunnRN.GrasbyPM.CowenPJ.Brain serotoninIA receptor binding measured by positron emission tomography with.[11C]WAY-1 00635: effects of depression and antidepressant treatment.Arch Gen Psychiatry.20005717418010665620
   PubMed Web of Science ®Google Scholar
• DrevetsWC.FrankE.PriceJC.et al.PET imaging of serotonin 1 A receptor binding in depression.Biol Psychiatry.1999461375138710578452
   PubMed Web of Science ®Google Scholar
• CheethamSC.CromptonMR.KatonaCL.NortonRW.Brain 5-HT1 binding sites in depressed suicides.Psychopharmacology19901025445482096412
   PubMed Web of Science ®Google Scholar
• StockmeierCA.ShapiroLA.DilleyGE.KolliTN.FriedmanL.RajkowskaG.Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity.J Neurosci.199818739474019736659
   PubMed Web of Science ®Google Scholar
• ToczekMT.CarsonRE.LangL.et al.PET imaging of 5-HT1 A receptor binding in patients with temporal lobe epilepsy.Neurology.20036074975612629228
   PubMed Web of Science ®Google Scholar
• SavicI.LindstromP.GulyasB.HalldinC.AndreeB.FardeL.Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy.Neurology.2004621343135115111672
   PubMed Web of Science ®Google Scholar
• MerletI.OstrowskyK.CostesN.RyvlinP.IsnardJ.FaillenotI.LavenneF.DufournelD.Le BarsD.MauguiereF.5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an.[18F]MPPF-PET study.Brain.200412790091314985263
   PubMed Web of Science ®Google Scholar
• MeschaksA.LindstromP.HalldinC.FardeL.SavicI.Regional reductions in serotonin 1A receptor binding in Juvenile Myoclonic Epilepsy.Arch Neurol.20056294696015956165
   PubMedGoogle Scholar
• HaslerG.BonwetschR.GiovacchiniG.et al.5-HT(1A) receptor binding in temporal lobe epilepsy patients with and without major depression.Biol Psychiatry.2008 In press
   PubMed Web of Science ®Google Scholar
• TheodoreWH.GiovacchiniG.BonwetschR.et al.The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography.Epilepsia.20064749950316529612
   PubMed Web of Science ®Google Scholar
• GilliamFG.MatonBM.MartinRC.et al.Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy.Neurology.20076836436817261683
   PubMed Web of Science ®Google Scholar
• ForsgrenL.NystromL.An incident case referent study of epileptic seizures in adults.Epilepsy Res.1999666812357957
   PubMedGoogle Scholar
• HesdorfferDC.HauserWA.AnnegersJF.et al.Major depression is a risk factor for seizures in older adults.Ann Neurol.20004724624910665498
   PubMed Web of Science ®Google Scholar
• HesdorfferDC.HauserWA.OlafssonE.LudvigssonP.KjartanssonO.Depression and suicidal attempt as risk factor for incidental unprovoked seizures.Ann Neurol.200659354116217743
   PubMed Web of Science ®Google Scholar
• JonesJE.WatsonR.ShethR.et al.Psychiatric comorbidity in children with new onset epilepsy.Dev Med Child Neurol.20074949349717593119
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association1994
   Google Scholar
• McAfeeAT.ChilcottKE.JohannesCB.HornbuckleK.HauserWA.WalkerAM.The incidence of first unprovoked seizure in pediatric patients with and without psychiatric diagnsoses.Epilepsia.2007481075108217441988
   PubMed Web of Science ®Google Scholar
• HitirisN.MohanrajR.NorrieJ.SillsGJ.BrodieMJ.Predictors of pharmacoresistant epilepsy.Epilepsy Res.20077519219617628429
   PubMed Web of Science ®Google Scholar
• AnhouryS.BrownRJ.KrishnamoorthyES.TrimbleMR.Psychiatric outcome after temporal lobectomy: a predictive study.Epilepsia.2000411608161511114220
   PubMed Web of Science ®Google Scholar
• KannerAM.ByrneR.SmithMC.BalabanovA.FreyM.Does a lifetime history of depression predict a worse postsurgical seizure outcome following a temporal lobectomy?Ann Neurol.200660: (S: 10): 19 (Abstract)
   Web of Science ®Google Scholar
• ShelineYl.Brain structural changes associated with depression. In: Gilliam FG, Kanner AM, Sheline Yl, eds.Depression and Brain Dysfunction. London, UK: Taylor & Francis200685104
   Google Scholar